Literature DB >> 17383997

Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration.

S Y Cohen1, C Creuzot-Garcher, J Darmon, T Desmettre, J F Korobelnik, F Levrat, G Quentel, S Paliès, A Sanchez, A Solesse de Gendre, H Schluep, M Weber, C Delcourt.   

Abstract

AIM: To describe the types and location of choroidal neovascularisation (CNV) in exudative age-related macular degeneration (AMD), including vascularised pigment epithelial detatchments (PED), and most recently described subtypes, such as retinal choroidal anasmostosis, also termed "retinal angiomatous proliferation" (RAP).
METHODS: Prospective multicentre consecutive descriptive case series. A total of 207 consecutive cases of newly diagnosed exudative AMD undergoing fluorescein angiography (FA) were recruited by 7 French referral hospital-based or private centres. Indocyanine green angiography (ICG) also was performed, when judged necessary by investigators. Types and location of CNV were classified by two independent experts and adjudicated by a third when discordant.
RESULTS: All patients had FA, while ICG was performed in 50% of subjects. A total of 17.6% had classic CNV only, 5.4% and 8.3% had predominantly and minimally classic CNV, respectively. Occult CNV could be classified in occult CNV without PED (32.7%) and occult CNV with PED, ie, vascularised PED (23.9%). RAP was observed in 15.1% of cases, and accounted for 30% of vascularised PED. In 5.8% of the cases there was haemorrhagic AMD and 4.8% had fibrovascular scars. Lesions were mainly subfoveal (80%). Agreement between the centre's ophthalmologist and the final validated expert classification was moderate (kappa = 0.52 for location and 0.59 for type of lesion).
CONCLUSION: This study confirms that newly diagnosed cases of exudative AMD are mainly occult and subfoveal. RAP appeared as a common lesion in patients with newly diagnosed exudative AMD.

Entities:  

Mesh:

Year:  2007        PMID: 17383997      PMCID: PMC1954889          DOI: 10.1136/bjo.2007.115501

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  20 in total

1.  Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.

Authors:  Ruth Axer-Siegel; Rita Ehrlich; Irit Rosenblatt; Michal Kramer; Ethan Priel; Yuval Yassur; Dov Weinberger
Journal:  Arch Ophthalmol       Date:  2004-04

2.  Retinal angiomatous proliferation: association with clinical and angiographic features.

Authors:  Maria Carla Donati; Gianluca Carifi; Gianni Virgili; Ugo Menchini
Journal:  Ophthalmologica       Date:  2006       Impact factor: 3.250

3.  Choroidal neovascular membranes: reproducibility of angiographic interpretation.

Authors:  S M Friedman; C E Margo
Journal:  Am J Ophthalmol       Date:  2000-12       Impact factor: 5.258

4.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

5.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

Authors:  N M Bressler
Journal:  Arch Ophthalmol       Date:  2001-02

6.  Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration.

Authors:  J S Slakter; L A Yannuzzi; U Schneider; J A Sorenson; A Ciardella; D R Guyer; R F Spaide; K B Freund; D A Orlock
Journal:  Ophthalmology       Date:  2000-04       Impact factor: 12.079

7.  Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-study).

Authors:  Frank G Holz; Jork Jorzik; Florian Schutt; Ulrike Flach; Kristina Unnebrink
Journal:  Ophthalmology       Date:  2003-02       Impact factor: 12.079

8.  Angiographic and flow patterns of retinal choroidal anastomoses in age-related macular degeneration with occult choroidal neovascularization.

Authors:  Ruth Axer-Siegel; Dan Bourla; Ethan Priel; Yuval Yassur; Dov Weinberger
Journal:  Ophthalmology       Date:  2002-09       Impact factor: 12.079

9.  Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration.

Authors:  Timothy W Olsen; Xiao Feng; Terrance J Kasper; Pamela P Rath; Eric R Steuer
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

10.  Age-related macular degeneration and blindness due to neovascular maculopathy.

Authors:  F L Ferris; S L Fine; L Hyman
Journal:  Arch Ophthalmol       Date:  1984-11
View more
  35 in total

1.  Long-term visual outcomes of intravitreal ranibizumab treatment for wet age-related macular degeneration and effect on blindness rates in south-east Scotland.

Authors:  S Borooah; V S Jeganathan; A-M Ambrecht; D Oladiwura; M Gavin; B Dhillon; P Cackett
Journal:  Eye (Lond)       Date:  2015-06-05       Impact factor: 3.775

2.  Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation.

Authors:  Han Joo Cho; Tae Gon Lee; Sang Youn Han; Hyoung Seok Kim; Jae Hui Kim; Jung Il Han; Young Ju Lew; Jong Woo Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-01       Impact factor: 3.117

3.  Difference in treatment burden of neovascular age-related macular degeneration among different types of neovascularization.

Authors:  Ji Hyun Lee; Jae Hui Kim; Jong Woo Kim; Chul Gu Kim; Dong Won Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-06       Impact factor: 3.117

4.  Surgical treatment for neovascularized retinal pigment epithelial detachment in age-related macular degeneration.

Authors:  Hui Li; Ding Xu; Hao Wang; Fang Wang
Journal:  Int J Ophthalmol       Date:  2013-02-18       Impact factor: 1.779

5.  Patient characteristics and treatment of neovascular age-related macular degeneration in France: the LUEUR1 observational study.

Authors:  Salomon-Yves Cohen; Eric H Souied; Michel Weber; Gérard Dupeyron; Gérard de Pouvourville; Michel Lievre; Anne Ponthieux
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-06       Impact factor: 3.117

Review 6.  Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis.

Authors:  Mohammad Hossein Jabbarpoor Bonyadi; Mehdi Yaseri; Mortaza Bonyadi; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2016-12-22       Impact factor: 2.031

7.  Cellular and 3D optical coherence tomography assessment during the initiation and progression of retinal degeneration in the Ccl2/Cx3cr1-deficient mouse.

Authors:  Yongdong Zhou; Kristopher G Sheets; Eric J Knott; Cornelius E Regan; Jingsheng Tuo; Chi-Chao Chan; William C Gordon; Nicolas G Bazan
Journal:  Exp Eye Res       Date:  2011-08-16       Impact factor: 3.467

8.  Characteristics of age-related macular degeneration in patients with diabetic retinopathy.

Authors:  Tadanobu Yoshikawa; Nahoko Ogata; Mitsumasa Wada; Tsuyoshi Otsuji; Kanji Takahashi
Journal:  Jpn J Ophthalmol       Date:  2011-05-03       Impact factor: 2.447

9.  Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation.

Authors:  Masaaki Saito; Tomohiro Iida; Mariko Kano
Journal:  Jpn J Ophthalmol       Date:  2012-12-04       Impact factor: 2.447

10.  Prevalence and risk factors of early-stage age-related macular degeneration in patients examined at a health promotion center in Korea.

Authors:  Byung Gil Moon; Soo Geun Joe; Jong-uk Hwang; Hong Kyu Kim; Jaewon Choe; Young Hee Yoon
Journal:  J Korean Med Sci       Date:  2012-04-25       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.